David Ford
Human Resources Officer presso PROTHENA CORPORATION PLC
Profilo
Currently, David Ford holds the position of Chief People Officer at Prothena Corp.
Plc.
Mr. Ford is also on the board of Lightpoint Medical Ltd.
He previously held the position of Chief Human Resources Officer at Intercept Pharmaceuticals, Inc., Vice President-Human Resources of Genzyme Corp., Director-Human Resources of Sanofi-Synthélabo Ltd., Vice President-Human Resources at Sanofi US Services, Inc. and Director-Human Resources at Sanofi-Synthélabo Ireland Ltd.
Mr. Ford received an MBA from INSEAD.
Posizioni attive di David Ford
Società | Posizione | Inizio |
---|---|---|
PROTHENA CORPORATION PLC | Human Resources Officer | 04/03/2024 |
Lightpoint Medical Ltd.
Lightpoint Medical Ltd. Medical SpecialtiesHealth Technology Lightpoint Medical Ltd. develops imaging technology for cancer surgery. It has developed a groundbreaking surgical imaging technology based on Cerenkov Luminescence Imaging(CLI). The firm's CLI has the potential to detect cancer in real-time during surgery, and thereby reduce the need for repeat operations. The company was founded by David Tuch in 2012 and is headquartered in Chesham, the United Kingdom. | Director/Board Member | - |
Precedenti posizioni note di David Ford
Società | Posizione | Fine |
---|---|---|
INTERCEPT PHARMACEUTICALS, INC. | Human Resources Officer | 01/12/2023 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Human Resources Officer | 01/05/2017 |
Sanofi US Services, Inc.
Sanofi US Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi US Services, Inc. engages in the research, production and distribution of pharmaceutical products. The private company is based in Bridgewater, NJ. | Human Resources Officer | 01/12/2015 |
Sanofi-Synthélabo Ireland Ltd. | Human Resources Officer | - |
Sanofi-Synthélabo Ltd.
Sanofi-Synthélabo Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi-Synthélabo Ltd. is a pharmaceutical company based in Reading, UK. The British company was founded in 1990 and specializes in manufacturing and distributing solid-dose and pharmaceutical products. | Human Resources Officer | - |
Formazione di David Ford
INSEAD | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
PROTHENA CORPORATION PLC | Health Technology |
Aziende private | 5 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Sanofi-Synthélabo Ltd.
Sanofi-Synthélabo Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi-Synthélabo Ltd. is a pharmaceutical company based in Reading, UK. The British company was founded in 1990 and specializes in manufacturing and distributing solid-dose and pharmaceutical products. | Health Technology |
Sanofi US Services, Inc.
Sanofi US Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi US Services, Inc. engages in the research, production and distribution of pharmaceutical products. The private company is based in Bridgewater, NJ. | Health Technology |
Lightpoint Medical Ltd.
Lightpoint Medical Ltd. Medical SpecialtiesHealth Technology Lightpoint Medical Ltd. develops imaging technology for cancer surgery. It has developed a groundbreaking surgical imaging technology based on Cerenkov Luminescence Imaging(CLI). The firm's CLI has the potential to detect cancer in real-time during surgery, and thereby reduce the need for repeat operations. The company was founded by David Tuch in 2012 and is headquartered in Chesham, the United Kingdom. | Health Technology |
Sanofi-Synthélabo Ireland Ltd. |